NPM1 and breast cancer: GRK5 was identified to phosphorylate nucleophosmin (NPM1), therefore regulating sensitivity to polo-like kinase inhibitor-induced apoptosis of breast cancer cells21, and its upregulation mediated by tazarotene-induced gene 1 (TIG1) significantly suppresses colon cancer growth22.